NCT03941639 Using Imaging Data and Genomic Data to Predict Metastasis of Breast Cancer After Treatment Status TERMINATED Phase N/A
NCT03940625 Anthracycline Induced Cardiotoxicity - Early Detection by Combination of Diastolic Strain and T2-mapping Status COMPLETED Phase NA
NCT03940092 Sodium (23Na) MRI for Tumour Characterisation and Assessment of Therapy Response in Breast Cancer Status RECRUITING Phase N/A
NCT03939156 Patients' Preferences for Adjuvant Endocrine Therapy in Early Breast Cancer Status UNKNOWN Phase N/A
NCT03936933 Pharmacodynamic Study Goserelin 3.6mg Injection Administered Subcutaneously in Premenopausal Patients with Breast Cancer Status TERMINATED Phase PHASE3
NCT03936478 Real-Time MRI-Guided 3-Fraction Accelerated Partial Breast Irradiation in Early Breast Cancer Status RECRUITING Phase PHASE2
NCT03934827 MRx0518 in Patients With Solid Tumours Waiting Surgical Removal of the Tumour Status UNKNOWN Phase PHASE1
NCT03933982 A Study of Pyrotinib Plus Vinorelbine in Patients With Brain Metastases From HER2-positive Metastatic Breast Cancer Status UNKNOWN Phase PHASE2
NCT03931928 Genotype and Phenotype Guided Supplementation of TAMoxifen Standard Therapy With ENDOXifen in Breast Cancer Patients Status COMPLETED Phase PHASE2
NCT03927768 Abbreviated Breast MRI (AB-MRI) With Golden-angle Radial Compressed-sensing and Parallel Imaging (GRASP) Status ACTIVE_NOT_RECRUITING Phase N/A
NCT03926091 Study Comparing 4 Cycles With 6 Cycles of TC (Docetaxel+Cyclophosphamide) Adjuvant Chemotherapy for 1-3 Lymph Node Positive ER+/HER2- Early Breast Cancer Status RECRUITING Phase PHASE3
NCT03924609 Impact of Intensive Follow-up for Bone Metastasis on Characteristics and Prognosis of Chinese Breast Cancer Patients Status COMPLETED Phase N/A
NCT03924011 Photobiomodulation Therapy for the Prevention of Acute Radiodermatitis in Breast Cancer Patients Undergoing Radiotherapy Status COMPLETED Phase NA
NCT03923504 Improving Exercise Capacity With Tailored Physical Activity in Lymphoma & Breast Cancer Patients Undergoing Tx Status COMPLETED Phase NA
NCT03923179 Phase II Clinical Study of Pyrotinib Combined With Etoposide to Treat HER2-positive Advanced Breast Cancer Status UNKNOWN Phase PHASE2